Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
I-Mab
Watchlist
I-Mab (天境生物) IPO Trading: Tiny Float and Undemanding Valuation
Equity Capital Markets
563 Views
17 Jan 2020 03:27
I-Mab (IMAB US) raised USD 104 million at USD 14.0 per ADS, above the mid-point of the IPO price range. I-Mab will start trading today. We have...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
I-Mab to Divest Chinese Assets and Business Operations for up to $80M - An Escape by Crafty Scheme
Quick Ideas #6
I-Mab (IMAB.US) - An "Entertaining Bet": To Be a Dark Horse or to Fail Completely
I-Mab BioPharma (IMAB US) – Ph2 Data of Lemzoparlimab (CD47) In 1L MDS Released
I-Mab BioPharma (IMAB US) – Strong Cash Balance to Fund Business Operations
Trending Collections
More »
Index Rebalance
Japan
India
Equity Bottom-Up
Event-Driven
Sell / Short Ideas
Philippines
South Korea
Singapore REITs
US ECM
Trending Insights
More »
GMO Internet (4784) - Shares Appear Manipulated/Squeezed (Again), but ParentCo MUST SELL
[Japan M&A] Polaris MBO for DD Group (3073) - Too Light But Probably a Done Deal
TOPIX Inclusions: Who Is Ready (Jul 2025)
Tuning Tariff Impact Estimates
ASX200 Index AdHoc Rebalance Preview: Potential Replacement for Spartan Resources (SPR AU)
Top Unpaywalled Insights
More »
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
US Equities Hit All-Time Highs—but Are Markets Ignoring Growing Risks?
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
I-Mab (IMAB US) - Insights On Core Products TJC4, TJ202 and TJ101
29 Mar 2021
I-Mab Placement - Heading in the Right Direction
08 Feb 2021
I-Mab (天境生物) Lock-Up Expiry: A Differentiated Immunotherapy Player Worth Reverse Inquiry
08 Jul 2020
I-Mab (天境生物) IPO Trading: Tiny Float and Undemanding Valuation
17 Jan 2020
I-Mab (天境生物) IPO: Everest Deal a Valuation Booster
06 Jan 2020
I-Mab (天境生物) Pre-IPO: Strong Management and Investor Backing with Differentiated Products
04 Nov 2019
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x